{"public_id":"cl_9f538753131fb027b44de5719055ab53","status":"active","superseded_by_public_id":null,"corpus_id":240541392,"text":"Comprehensive genomic profiling provided 29 additional clinical trials for potential patient enrollment compared with the Oncomine Dx Target Test comparator panel.","confidence":0.97,"paper":{"corpus_id":240541392,"title":"Improvements in access to cancer clinical trials facilitated by comprehensive genomic profiling in non-small cell lung cancer.","url":"https://sah.borca.ai/papers/240541392"},"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":1},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_3367263c10070497dbc59376265be794","name":"comprehensive genomic profiling","description":"A cancer genomic testing approach represented in the abstract by FoundationOne CDx with 324 genes.","types":["testing approach"],"url":"https://sah.borca.ai/concepts/co_3367263c10070497dbc59376265be794"},{"public_id":"co_4622081c7da4e49f19fa9bd57214c892","name":"Oncomine Dx Target Test","description":"The commercially available 23-gene comparator panel used against comprehensive genomic profiling.","types":["genomic test","comparator"],"url":"https://sah.borca.ai/concepts/co_4622081c7da4e49f19fa9bd57214c892"},{"public_id":"co_f80408534c2a09fa76f93907b24ab6f1","name":"additional clinical trials","description":"Trials potentially available to patients because comprehensive genomic profiling detects markers beyond the comparator panel.","types":["trial outcome"],"url":"https://sah.borca.ai/concepts/co_f80408534c2a09fa76f93907b24ab6f1"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_9f538753131fb027b44de5719055ab53"}